Aaron Cantor is a Dermatology physician affiliated with Naval Medical Center Portsmouth. OpenAlex indexes 13 publications with 245 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year20253 payments
- LEO Pharma Inc.Program year20253 payments
- GENZYME CORPORATIONProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
38.8%Corticosteroid25.7%Triamcinolone Acetonide84%Triamcinolone acetonide16%Part D + Part B≥44 patientsAzole Antifungal8.7%Clotrimazole100%Part D≥13 patients+ 1 more class in this area
Sensory organs
19%Corticosteroid19%Clobetasol Propionate79%Hydrocortisone22%Part D≥26 patientsAnti-infectives
16.9%Azole Antifungal8.5%Ketoconazole100%Part D≥16 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor4.7%Valacyclovir100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 28422 Fibroepithelioma of Pinkus as an indicator of internal malignancy
Journal of the American Academy of Dermatology
2021 - Parkinson’s Disease as a Risk Factor for Melanoma: A Review
SKIN The Journal of Cutaneous Medicine
2021 - Fingernail Abnormalities After a Systemic Illness.
PubMed
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Leah Spring, DO
Naval Medical Center Portsmouth
George Balazs, MD
Naval Medical Center Portsmouth
Joseph Slakey, MD
Naval Medical Center Portsmouth
Mario Cardoso, MD, DC
Naval Medical Center Portsmouth
Robert Modlin, MD
University of California, Los Angeles
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Joel Gelfand, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”